The US Plans First Vaccinations to Start Before Mid-December, Pfizer-BioNTech Application Under Review

3 min read | November 23, 2020 05:12 PM AEDT | By Team Kalkine Media

Summary

  • The US expects to start vaccinating residents by 11th-12th December according to the head of Operation Warp Speed, Moncef Slaoui.
  • 70% immunization could allow the country to achieve herd immunity. Mr Slaoni believes it is possible by May though NIAID Director, Anthony Fauci thinks otherwise.
  • BioNTech and Pfizer have requested an Emergency Use Authorization from the US FDA for their vaccine candidate; the decision could take up to three weeks.

After the deadly COVID-19 pandemic hit the world, all eyes moved to how soon will there be a vaccine for the fatal virus, SARS-CoV-2. Speculations started building regarding the same, and we are already beyond the initial deadline set for September 2020. However, things have begun to look positive as vaccine makers are posting positive results and countries are planning for vaccination process to begin.

In the latest development, Moncef Slaoui, the head of the federal government’s Operation Warp Speed said that the US is expected to begin vaccinations against COVID-19 in less than three weeks. This means that the process of immunizing first people across all states will commence around 11 December 2020.

DO WATCH: When will Pfizer & Moderna Vaccines be available?

Pfizer-BioNTech apply EUA application; Experts believe herd immunity can be achieved by May

A 70% immunization rate across the US by around May is also part of the plan, which could allow for herd immunity to take place according to Mr Slaoni. The US government's top infectious disease specialist Anthony Fauci said that it was possible to achieve herd immunity if a sufficient number of people receive the vaccine; however, he did not think it was possible by May.

The race to COVID-19 vaccination is not only to make people safe but also to ensure people develop immunity before life returns to normal. The wide distribution of an effective vaccine in 2021 might not be as easy as it sounds, and various hurdles are expected in the process.

Lately, BioNTech and Pfizer have requested an emergency authorization from the US Food and Drug Administration for their vaccine, but the process is expected to take weeks. Stephen Hahn, FDA Commissioner on Twitter, said that although the time taken by FDA in reviewing the vaccine cannot be predicted, yet the agency shall assess the request as expeditiously as possible. Moreover, in doing so, the evaluation shall go through a thorough, science-based manner to present a vaccine that the American people ought to have as quickly as practicable.

It has been a year since the first case of COVID-19 was detected, and people seem desperate to return to normal. However, there has been a significant amount of carelessness also from the general public in avoiding COVID-19, despite rising cases and the governments raising alarms to follow the guidelines.

For several reasons like these, countries have started witnessing significant repercussions like the second wave of COVID-19 and intense restrictions. It is imperative that countries across the globe begin the vaccination process as soon as an effective vaccine is in the market.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.